Related Articles
Assessment of ALK gene fusions in lung cancer using the differential expression and exon integrity methods
Clinicopathological features and diagnostic methods of ALK fusion‑positive non‑small cell lung cancer in Korea
Evaluation of immunohistochemistry using two different antibodies and procedures for primary lung adenocarcinoma harboring anaplastic lymphoma kinase rearrangement
Marked tumor response to crizotinib after 4 years of maintenance pemetrexed in a patient with anaplastic lymphoma kinase‑positive non‑small‑cell lung cancer
Identification of anaplastic lymphoma kinase fusions in clear cell renal cell carcinoma